MedTrace Logo

Aqueous Mushroom Extract and Intraocular Pressure

NCT01017068 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2009-11-25

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of Aqueous mushroom extract (AME) on intra ocular pressure (IOP) in humans or as a potential anti glaucoma drug.

Conditions

Interventions

DRUG

OME

4g/100ml) dose: п gutt tid x 1/52

DRUG

OME

(2g/100ml) dose: п gutt tid x 1/52

DRUG

OME

(1g/100ml) dose: п gutt tid x 1/52

DRUG

OME

(4g/100ml) dose: п gutt tid x 1/52

DRUG

OME

(2g/100ml) dose: п gutt tid x 1/52

DRUG

OME

(1g/100ml) dose: п gutt tid x 1/52

Sponsors & Collaborators

  • University of Benin

    lead OTHER

Principal Investigators

  • VINCENT I IYAWE, MD, PhD · University of Benin, Benin City Nigeria

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01017068 on ClinicalTrials.gov